Journal of Pharmacy And Bioallied Sciences
Journal of Pharmacy And Bioallied Sciences Login  | Users Online: 2875  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 
    Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission


    Article Cited by others

ORIGINAL ARTICLE

Subcutaneous implants for long-acting drug therapy in laboratory animals may generate unintended drug reservoirs

Guarnieri Michael, Tyler Betty M, DeTolla Louis, Zhao Ming, Kobrin Barry

Year : 2014| Volume: 6| Issue : 1 | Page no: 38-42

   This article has been cited by
 
1 Probuphine® (buprenorphine implant): a promising candidate in opioid dependence
Preeti Barnwal,Saibal Das,Somnath Mondal,Anand Ramasamy,Tanay Maiti,Arunava Saha
Therapeutic Advances in Psychopharmacology. 2017; 7(3): 119
[Pubmed]  [Google Scholar] [DOI]
2 Evaluation of buprenorphine hydrochloride Pluronic® gel formulation in male C57BL/6NCrl mice
Terry L. Blankenship-Paris,John W. Dutton,David R. Goulding,Christopher A. McGee,Grace E. Kissling,Page H. Myers
Lab Animal. 2016; 45(10): 370
[Pubmed]  [Google Scholar] [DOI]
3 Subcutaneous Implants of Buprenorphine-Cholesterol-Triglyceride Powder in Mice
L. DeTolla,R. Sanchez,E. Khan,B. Tyler,M. Guarnieri
Journal of Veterinary Medicine. 2014; 2014: 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article